[
  {
    "title": "APRT",
    "content": "",
    "level": 1,
    "index": 0,
    "sentences": []
  },
  {
    "title": "Lead",
    "content": "**Adenine phosphoribosyltransferase** (**APRTase**) is an [enzyme](https://en.wikipedia.org/wiki/Enzyme) encoded by the *APRT* [gene](https://en.wikipedia.org/wiki/Gene), found in [humans](https://en.wikipedia.org/wiki/Human) on [chromosome 16](https://en.wikipedia.org/wiki/Chromosome_16). It is part of the Type I PRTase family and is involved in the [nucleotide salvage](https://en.wikipedia.org/wiki/Nucleotide_salvage) pathway, which provides an alternative to [nucleotide](https://en.wikipedia.org/wiki/Nucleotide) biosynthesis de novo in humans and most other animals. In parasitic [protozoa](https://en.wikipedia.org/wiki/Protozoa) such as [giardia](https://en.wikipedia.org/wiki/Giardia), APRTase provides the sole mechanism by which AMP can be produced. APRTase deficiency contributes to the formation of kidney stones ([urolithiasis](https://en.wikipedia.org/wiki/Urolithiasis)) and to potential [kidney failure](https://en.wikipedia.org/wiki/Kidney_failure).",
    "level": 2,
    "index": 1,
    "sentences": [
      "**Adenine phosphoribosyltransferase** (**APRTase**) is an [enzyme](https://en.wikipedia.org/wiki/Enzyme) encoded by the *APRT* [gene](https://en.wikipedia.org/wiki/Gene), found in [humans](https://en.wikipedia.org/wiki/Human) on [chromosome 16](https://en.wikipedia.org/wiki/Chromosome_16).",
      "It is part of the Type I PRTase family and is involved in the [nucleotide salvage](https://en.wikipedia.org/wiki/Nucleotide_salvage) pathway, which provides an alternative to [nucleotide](https://en.wikipedia.org/wiki/Nucleotide) biosynthesis de novo in humans and most other animals.",
      "In parasitic [protozoa](https://en.wikipedia.org/wiki/Protozoa) such as [giardia](https://en.wikipedia.org/wiki/Giardia), APRTase provides the sole mechanism by which AMP can be produced.",
      "APRTase deficiency contributes to the formation of kidney stones ([urolithiasis](https://en.wikipedia.org/wiki/Urolithiasis)) and to potential [kidney failure](https://en.wikipedia.org/wiki/Kidney_failure)."
    ]
  },
  {
    "title": "Function",
    "content": "APRTase catalyzes the following reaction in the purine [nucleotide salvage](https://en.wikipedia.org/wiki/Nucleotide_salvage) pathway:\n\nAdenine + Phosphoribosyl Pyrophosphate ([PRPP](https://en.wikipedia.org/wiki/Phosphoribosyl_pyrophosphate)) \u2192 Adenylate ([AMP](https://en.wikipedia.org/wiki/Adenosine_monophosphate)) + Pyrophosphate ([PPi](https://en.wikipedia.org/wiki/Pyrophosphate))\n\nIn organisms that can synthesize [purines](https://en.wikipedia.org/wiki/Purine) de novo, the nucleotide salvage pathway provides an alternative that is energetically more efficient. It can salvage adenine from the [polyamine](https://en.wikipedia.org/wiki/Polyamine) biosynthetic pathway or from dietary sources of purines. Although APRTase is functionally redundant in these organisms, it becomes more important during periods of rapid growth, such as embryogenesis and tumor growth. It is constitutively expressed in all mammalian tissue.\n\nIn [protozoan](https://en.wikipedia.org/wiki/Protozoan) parasites, the nucleotide salvage pathway provides the sole means for nucleotide synthesis. Since the consequences of APRTase deficiency in humans is comparatively mild and treatable, it may be possible to treat certain [parasitic infections](https://en.wikipedia.org/wiki/Parasitic_infection) by targeting APRTase function.\n\nIn [plants](https://en.wikipedia.org/wiki/Plant), as in other organisms, ARPTase functions primarily for the synthesis of [adenylate](https://en.wikipedia.org/wiki/Adenylate). It has the unique ability to metabolize [cytokinins](https://en.wikipedia.org/wiki/Cytokinin)\u2014a [plant hormone](https://en.wikipedia.org/wiki/Plant_hormone) that can exist as a [base](https://en.wikipedia.org/wiki/Base_(chemistry)), [nucleotide](https://en.wikipedia.org/wiki/Nucleotide), or [nucleoside](https://en.wikipedia.org/wiki/Nucleoside)\u2014into adenylate nucleotides.\n\nAPRT is functionally related to [hypoxanthine-guanine phosphoribosyltransferase](https://en.wikipedia.org/wiki/Hypoxanthine-guanine_phosphoribosyltransferase) (HPRT).",
    "level": 2,
    "index": 2,
    "sentences": [
      "APRTase catalyzes the following reaction in the purine [nucleotide salvage](https://en.wikipedia.org/wiki/Nucleotide_salvage) pathway:\n\nAdenine + Phosphoribosyl Pyrophosphate ([PRPP](https://en.wikipedia.org/wiki/Phosphoribosyl_pyrophosphate)) \u2192 Adenylate ([AMP](https://en.wikipedia.org/wiki/Adenosine_monophosphate)) + Pyrophosphate ([PPi](https://en.wikipedia.org/wiki/Pyrophosphate))\n\nIn organisms that can synthesize [purines](https://en.wikipedia.org/wiki/Purine) de novo, the nucleotide salvage pathway provides an alternative that is energetically more efficient.",
      "It can salvage adenine from the [polyamine](https://en.wikipedia.org/wiki/Polyamine) biosynthetic pathway or from dietary sources of purines.",
      "Although APRTase is functionally redundant in these organisms, it becomes more important during periods of rapid growth, such as embryogenesis and tumor growth.",
      "It is constitutively expressed in all mammalian tissue.",
      "In [protozoan](https://en.wikipedia.org/wiki/Protozoan) parasites, the nucleotide salvage pathway provides the sole means for nucleotide synthesis.",
      "Since the consequences of APRTase deficiency in humans is comparatively mild and treatable, it may be possible to treat certain [parasitic infections](https://en.wikipedia.org/wiki/Parasitic_infection) by targeting APRTase function.",
      "In [plants](https://en.wikipedia.org/wiki/Plant), as in other organisms, ARPTase functions primarily for the synthesis of [adenylate](https://en.wikipedia.org/wiki/Adenylate).",
      "It has the unique ability to metabolize [cytokinins](https://en.wikipedia.org/wiki/Cytokinin)\u2014a [plant hormone](https://en.wikipedia.org/wiki/Plant_hormone) that can exist as a [base](https://en.wikipedia.org/wiki/Base_(chemistry)), [nucleotide](https://en.wikipedia.org/wiki/Nucleotide), or [nucleoside](https://en.wikipedia.org/wiki/Nucleoside)\u2014into adenylate nucleotides.",
      "APRT is functionally related to [hypoxanthine-guanine phosphoribosyltransferase](https://en.wikipedia.org/wiki/Hypoxanthine-guanine_phosphoribosyltransferase) (HPRT)."
    ]
  },
  {
    "title": "Structure",
    "content": "APRTase is a [homodimer](https://en.wikipedia.org/wiki/Homodimer), with 179 [amino acid](https://en.wikipedia.org/wiki/Amino_acid) residues per [monomer](https://en.wikipedia.org/wiki/Monomer). Each monomer contains the following regions:\n\n- \"Core\" domain (residues 33-169) with five parallel [\u03b2-sheets](https://en.wikipedia.org/wiki/Beta_sheet)\n- \"Hood\" domain (residues 5-34) with 2 [\u03b1-helices](https://en.wikipedia.org/wiki/Alpha_helix) and 2 \u03b2-sheets\n- \"Flexible loop\" domain (residues 95-113) with 2 antiparallel \u03b2-sheets\n\nThe core is highly conserved across many PRTases. The hood, which contains the [adenine](https://en.wikipedia.org/wiki/Adenine) [binding site](https://en.wikipedia.org/wiki/Binding_site), has more variability within the family of enzymes. A 13-residue motif comprises the [PRPP](https://en.wikipedia.org/wiki/Phosphoribosyl_pyrophosphate) binding region and involves two adjacent [acidic](https://en.wikipedia.org/wiki/Acid) residues and at least one surrounding [hydrophobic](https://en.wikipedia.org/wiki/Hydrophobic_interaction) residue.\n\nThe enzyme's specificity for adenine involves hydrophobic residues [Ala131](https://en.wikipedia.org/wiki/Alanine) and [Leu159](https://en.wikipedia.org/wiki/Leucine) in the core domain. In humans, two residues in the hood domain [hydrogen bond](https://en.wikipedia.org/wiki/Hydrogen_bond) with the purine for further specificity: [Val25](https://en.wikipedia.org/wiki/Valine) with the [hydrogens](https://en.wikipedia.org/wiki/Hydrogen) on N6, and [Arg27](https://en.wikipedia.org/wiki/Arginine) with N1. Although the flexible loop does not interact with the hood during purine recognition, it is thought to close over the [active site](https://en.wikipedia.org/wiki/Active_site) and sequester the reaction from [solvents](https://en.wikipedia.org/wiki/Solvent).\n\nMost research on APRTase reports that Mg\u00b2\u207a is essential for phosphoribosyl transfer, and this is conserved across Type I PRTases. However, a recent effort to resolve the structure of human APRTase was unable to locate a single site for Mg\u00b2\u207a, but did find evidence to suggest a Cl\u207b atom near Trp98. Despite the difficulty of placing Mg\u00b2\u207a, it is generally accepted that the [catalytic mechanism](https://en.wikipedia.org/wiki/Enzyme_catalysis) is dependent on this ion.",
    "level": 2,
    "index": 3,
    "sentences": [
      "APRTase is a [homodimer](https://en.wikipedia.org/wiki/Homodimer), with 179 [amino acid](https://en.wikipedia.org/wiki/Amino_acid) residues per [monomer](https://en.wikipedia.org/wiki/Monomer).",
      "Each monomer contains the following regions:\n\n- \"Core\" domain (residues 33-169) with five parallel [\u03b2-sheets](https://en.wikipedia.org/wiki/Beta_sheet)\n- \"Hood\" domain (residues 5-34) with 2 [\u03b1-helices](https://en.wikipedia.org/wiki/Alpha_helix) and 2 \u03b2-sheets\n- \"Flexible loop\" domain (residues 95-113) with 2 antiparallel \u03b2-sheets\n\nThe core is highly conserved across many PRTases.",
      "The hood, which contains the [adenine](https://en.wikipedia.org/wiki/Adenine) [binding site](https://en.wikipedia.org/wiki/Binding_site), has more variability within the family of enzymes.",
      "A 13-residue motif comprises the [PRPP](https://en.wikipedia.org/wiki/Phosphoribosyl_pyrophosphate) binding region and involves two adjacent [acidic](https://en.wikipedia.org/wiki/Acid) residues and at least one surrounding [hydrophobic](https://en.wikipedia.org/wiki/Hydrophobic_interaction) residue.",
      "The enzyme's specificity for adenine involves hydrophobic residues [Ala131](https://en.wikipedia.org/wiki/Alanine) and [Leu159](https://en.wikipedia.org/wiki/Leucine) in the core domain.",
      "In humans, two residues in the hood domain [hydrogen bond](https://en.wikipedia.org/wiki/Hydrogen_bond) with the purine for further specificity: [Val25](https://en.wikipedia.org/wiki/Valine) with the [hydrogens](https://en.wikipedia.org/wiki/Hydrogen) on N6, and [Arg27](https://en.wikipedia.org/wiki/Arginine) with N1.",
      "Although the flexible loop does not interact with the hood during purine recognition, it is thought to close over the [active site](https://en.wikipedia.org/wiki/Active_site) and sequester the reaction from [solvents](https://en.wikipedia.org/wiki/Solvent).",
      "Most research on APRTase reports that Mg\u00b2\u207a is essential for phosphoribosyl transfer, and this is conserved across Type I PRTases.",
      "However, a recent effort to resolve the structure of human APRTase was unable to locate a single site for Mg\u00b2\u207a, but did find evidence to suggest a Cl\u207b atom near Trp98.",
      "Despite the difficulty of placing Mg\u00b2\u207a, it is generally accepted that the [catalytic mechanism](https://en.wikipedia.org/wiki/Enzyme_catalysis) is dependent on this ion."
    ]
  },
  {
    "title": "Mechanism",
    "content": "APRTase proceeds via a bi bi ordered sequential mechanism, involving the formation of a ternary complex. The enzyme first binds [PRPP](https://en.wikipedia.org/wiki/Phosphoribosyl_pyrophosphate), followed by [adenine](https://en.wikipedia.org/wiki/Adenine). After the phosphoribosyl transfer occurs, [pyrophosphate](https://en.wikipedia.org/wiki/Pyrophosphate) leaves first, followed by [AMP](https://en.wikipedia.org/wiki/Adenosine_monophosphate). Kinetic studies indicate that the phosphoribosyl transfer is relatively fast, while the product release (particularly the release of AMP) is [rate-limiting](https://en.wikipedia.org/wiki/Rate-determining_step).\n\nIn human APRTase, it is thought that adenine's N9 proton is abstracted by [Glu104](https://en.wikipedia.org/wiki/Glutamic_acid) to form an oxacarbenium [transition state](https://en.wikipedia.org/wiki/Transition_state). This functions as the [nucleophile](https://en.wikipedia.org/wiki/Nucleophile) to attack the [anomeric](https://en.wikipedia.org/wiki/Anomer) carbon of PRPP, forming AMP and displacing pyrophosphate from PRPP. The mechanism of APRTase is generally consistent with that of other PRTases, which conserve the function of displacing PRPP's \u03b1-1-pyrophosphate using a [nitrogen](https://en.wikipedia.org/wiki/Nitrogen) nucleophile, in either an S<sub>N</sub>1 or S<sub>N</sub>2 attack.",
    "level": 2,
    "index": 4,
    "sentences": [
      "APRTase proceeds via a bi bi ordered sequential mechanism, involving the formation of a ternary complex.",
      "The enzyme first binds [PRPP](https://en.wikipedia.org/wiki/Phosphoribosyl_pyrophosphate), followed by [adenine](https://en.wikipedia.org/wiki/Adenine).",
      "After the phosphoribosyl transfer occurs, [pyrophosphate](https://en.wikipedia.org/wiki/Pyrophosphate) leaves first, followed by [AMP](https://en.wikipedia.org/wiki/Adenosine_monophosphate).",
      "Kinetic studies indicate that the phosphoribosyl transfer is relatively fast, while the product release (particularly the release of AMP) is [rate-limiting](https://en.wikipedia.org/wiki/Rate-determining_step).",
      "In human APRTase, it is thought that adenine's N9 proton is abstracted by [Glu104](https://en.wikipedia.org/wiki/Glutamic_acid) to form an oxacarbenium [transition state](https://en.wikipedia.org/wiki/Transition_state).",
      "This functions as the [nucleophile](https://en.wikipedia.org/wiki/Nucleophile) to attack the [anomeric](https://en.wikipedia.org/wiki/Anomer) carbon of PRPP, forming AMP and displacing pyrophosphate from PRPP.",
      "The mechanism of APRTase is generally consistent with that of other PRTases, which conserve the function of displacing PRPP's \u03b1-1-pyrophosphate using a [nitrogen](https://en.wikipedia.org/wiki/Nitrogen) nucleophile, in either an S<sub>N</sub>1 or S<sub>N</sub>2 attack."
    ]
  },
  {
    "title": "Deficiency",
    "content": "When APRTase has reduced or nonexistent activity, [adenine](https://en.wikipedia.org/wiki/Adenine) accumulates from other pathways. It is degraded by [xanthine dehydrogenase](https://en.wikipedia.org/wiki/Xanthine_dehydrogenase) to [2,8-dihydroxyadenine](https://en.wikipedia.org/wiki/2,8-dihydroxyadenine) (DHA). Although DHA is protein-bound in [plasma](https://en.wikipedia.org/wiki/Blood_plasma), it has poor [solubility](https://en.wikipedia.org/wiki/Solubility) in [urine](https://en.wikipedia.org/wiki/Urine) and gradually precipitates in [kidney tubules](https://en.wikipedia.org/wiki/Nephron), leading to the formation of kidney stones ([urolithiasis](https://en.wikipedia.org/wiki/Urolithiasis)). If left untreated, the condition can eventually produce [kidney failure](https://en.wikipedia.org/wiki/Kidney_failure).\n\nARPTase deficiency was first diagnosed in the [UK](https://en.wikipedia.org/wiki/United_Kingdom) in 1976. Since then, two categories of APRTase deficiency have been defined in humans.\n\nType I deficiency results in a complete loss of APRTase activity and can occur in patients that are [homozygous](https://en.wikipedia.org/wiki/Homozygous) or [compound heterozygous](https://en.wikipedia.org/wiki/Compound_heterozygous) for various [mutations](https://en.wikipedia.org/wiki/Mutation). Sequencing has revealed many different mutations that can account for Type 1, including [missense mutations](https://en.wikipedia.org/wiki/Missense_mutation), [nonsense mutations](https://en.wikipedia.org/wiki/Nonsense_mutation), a duplicated set of 4 [base pairs](https://en.wikipedia.org/wiki/Base_pair) in [exon](https://en.wikipedia.org/wiki/Exon) 3, and a single [thymine](https://en.wikipedia.org/wiki/Thymine) [insertion](https://en.wikipedia.org/wiki/Insertion_(genetics)) in [intron](https://en.wikipedia.org/wiki/Intron) 4. These mutations cause effects that are clustered into three main areas: in the binding of PRPP's \u03b2-phosphate, in the binding of PRPP's 5'-phosphate, and in the segment of the flexible loop that closes over the active site during catalysis. Type I deficiency has been observed in various ethnic groups but studied predominately among [White](https://en.wikipedia.org/wiki/White_people) populations.\n\nType II deficiency causes APRTase to have a reduced affinity for PRPP, resulting in a tenfold increase in the K<sub>M</sub> value. It has been observed and studied primarily in [Japan](https://en.wikipedia.org/wiki/Japan).\n\nA diagnosis of APRTase deficiency can be made by analyzing [kidney stones](https://en.wikipedia.org/wiki/Kidney_stone), measuring DHA concentrations in urine, or analyzing APRTase activity in [erythrocytes](https://en.wikipedia.org/wiki/Erythrocyte). It is treatable with regular doses of [allopurinol](https://en.wikipedia.org/wiki/Allopurinol) or [febuxostat](https://en.wikipedia.org/wiki/Febuxostat), which inhibit xanthine dehydrogenase activity to prevent the accumulation and precipitation of DHA. The condition can also be attenuated with a low-purine diet and high fluid intake.",
    "level": 2,
    "index": 5,
    "sentences": [
      "When APRTase has reduced or nonexistent activity, [adenine](https://en.wikipedia.org/wiki/Adenine) accumulates from other pathways.",
      "It is degraded by [xanthine dehydrogenase](https://en.wikipedia.org/wiki/Xanthine_dehydrogenase) to [2,8-dihydroxyadenine](https://en.wikipedia.org/wiki/2,8-dihydroxyadenine) (DHA).",
      "Although DHA is protein-bound in [plasma](https://en.wikipedia.org/wiki/Blood_plasma), it has poor [solubility](https://en.wikipedia.org/wiki/Solubility) in [urine](https://en.wikipedia.org/wiki/Urine) and gradually precipitates in [kidney tubules](https://en.wikipedia.org/wiki/Nephron), leading to the formation of kidney stones ([urolithiasis](https://en.wikipedia.org/wiki/Urolithiasis)).",
      "If left untreated, the condition can eventually produce [kidney failure](https://en.wikipedia.org/wiki/Kidney_failure).",
      "ARPTase deficiency was first diagnosed in the [UK](https://en.wikipedia.org/wiki/United_Kingdom) in 1976.",
      "Since then, two categories of APRTase deficiency have been defined in humans.",
      "Type I deficiency results in a complete loss of APRTase activity and can occur in patients that are [homozygous](https://en.wikipedia.org/wiki/Homozygous) or [compound heterozygous](https://en.wikipedia.org/wiki/Compound_heterozygous) for various [mutations](https://en.wikipedia.org/wiki/Mutation).",
      "Sequencing has revealed many different mutations that can account for Type 1, including [missense mutations](https://en.wikipedia.org/wiki/Missense_mutation), [nonsense mutations](https://en.wikipedia.org/wiki/Nonsense_mutation), a duplicated set of 4 [base pairs](https://en.wikipedia.org/wiki/Base_pair) in [exon](https://en.wikipedia.org/wiki/Exon) 3, and a single [thymine](https://en.wikipedia.org/wiki/Thymine) [insertion](https://en.wikipedia.org/wiki/Insertion_(genetics)) in [intron](https://en.wikipedia.org/wiki/Intron) 4.",
      "These mutations cause effects that are clustered into three main areas: in the binding of PRPP's \u03b2-phosphate, in the binding of PRPP's 5'-phosphate, and in the segment of the flexible loop that closes over the active site during catalysis.",
      "Type I deficiency has been observed in various ethnic groups but studied predominately among [White](https://en.wikipedia.org/wiki/White_people) populations.",
      "Type II deficiency causes APRTase to have a reduced affinity for PRPP, resulting in a tenfold increase in the K<sub>M</sub> value.",
      "It has been observed and studied primarily in [Japan](https://en.wikipedia.org/wiki/Japan).",
      "A diagnosis of APRTase deficiency can be made by analyzing [kidney stones](https://en.wikipedia.org/wiki/Kidney_stone), measuring DHA concentrations in urine, or analyzing APRTase activity in [erythrocytes](https://en.wikipedia.org/wiki/Erythrocyte).",
      "It is treatable with regular doses of [allopurinol](https://en.wikipedia.org/wiki/Allopurinol) or [febuxostat](https://en.wikipedia.org/wiki/Febuxostat), which inhibit xanthine dehydrogenase activity to prevent the accumulation and precipitation of DHA.",
      "The condition can also be attenuated with a low-purine diet and high fluid intake."
    ]
  }
]
